Ella Nkhoma, Ph.D., M.B.A. Email and Phone Number
Ella Nkhoma is a performance-driven, analytical, and process-focused Data Science professional, showcasing an excellent ability to lead actionable data science insights and drive innovation to accelerate drug discovery/development and life cycle management initiatives. She offers 18+ years of transferable experience in facilitating seamless execution and delivery of end-to-end data science initiatives by devising and executing best-in-class research using real-world data analytics. She demonstrates subject matter expertise in epidemiology, biostatistics, data science, and machine learning tools, coupled with varied therapeutic area experience, including infectious diseases, cardiovascular, fibrosis, immunoscience, and neuroscience. During an accomplished career of continuous success and growth, Ella earned a winning reputation for providing in-depth analysis, leadership, and support to facilitate all phases of drug development based on real-world data insights as well as scientifically credible and high-quality evidence generation. She possesses a proven track record of success in consistently exceeding expectations, innovating to optimize drug discovery and development, and building cross-functional collaboration channels to drive long-term value. She provides data-driven and insightful recommendations via comprehensive reports and presentations to support organizational decision-making while communicating complex concepts in a clear manner to diverse audiences.Through dedication towards promoting a culture of collaboration and sustainability, Ella empowers and motivates diverse teams to achieve business objectives while administering coaching, mentoring, training, and development initiatives to elevate personnel performance and attain team synergy. She champions all aspects of epidemiology, real-world data, biostatistics, drug discovery and development process, quantitative analysis, latest scientific quantitative research methodologies, and pharmacoepidemiology. She earned a winning reputation for identifying robust, innovative, and efficient methods to conduct evidence-generation studies while providing scientific, methodological, and analytical expertise to execute a portfolio of analytic projects and initiatives.
Regeneron
View-
Senior Director, Heor EpidemiologyRegeneron Oct 2023 - PresentTarrytown, New York, Us
-
Executive Director, Data ScienceValo 2022 - Oct 2023Lexington, Ma, UsPROJECT MANAGEMENT | TEAM LEADERSHIP | STRATEGIC PARTNERSHIPSDATA STRATEGY LEADERSHIP | REAL WORLD DATA INSIGHTS | ML/AI APPROACHES• Assume a highly visible and multifaceted role as Data Science Team Lead, directing multiple innovation projects in close coordination with cohesive high-performing data science teams across quantitative disciplines.• Lead enterprise clinical and translational data strategy, including end-to-end need and gap assessments, evaluation, and execution with accuracy.• Liaise with Chief Innovation Officer and innovation team to create and drive value for the organization through strategic external partnerships.• Conceptualize novel approaches and workflows for clinical/translational data science capabilities.• Lead and manage matrix teams for translational projects across early discovery.• Create and implement best practices involving all aspects of data modeling and analysis.• Oversee early clinical development initiatives using real-world data.• Deliver actionable insights impacting discovery and development of novel medicines and drugs.• Combine technical expertise in pharmacoepidemiology and applied biostatistics to facilitate data science management activities by following industry best practices. -
Senior Director, Clinical Data ScienceValo 2021 - 2022Lexington, Ma, UsTEAM LEADERSHIP| REAL WORLD DATA INSIGHTS GENERATION | DRUG DISCOVERY | DRUG DEVELOPMENT| CAPABILITY BUILDING• Utilized advanced leadership capabilities while steering cross-functional teams, developing and implementing data generation strategies and approaches to facilitate target identification and validation in drug discovery.• Prioritized activities and resources across multiple projects from concept to execution, including insights generation to support clinical development programs, discovery efforts, and advanced analytical capability building.• Generated insights from real-world data to inform clinical trial design and discovery programs.• Managed high-performing team of data scientists to achieve strategic business goals and objectives.• Developed state-of-the-art models to uncover data insights, trends, and patterns with accuracy.• Orchestrated data for submissions, integrated analyses, evidence generation, and regulatory interactions.• Utilized artificial intelligence/machine learning solutions to optimize real world data analytics.
-
Senior Director, Rwe Quantitative Pharmacoepidemiology (Head)Gw Pharmaceuticals Plc 2021 - 2021Cambridge, GbREAL-WORLD EVIDENCE GENERATION | EXTERNAL COLLABORATIONS| DRUG SAFETY RESEARCH| EARLY CLINICAL DEVELOPMENT| LIFECYCLE MANAGEMENT • Designed departmental vision for new pharmacoepidemiology function to support product development, commercial, safety, and corporate stakeholders in an efficient and effective manner.• Performed an integral role, conceptualizing and implementing comprehensive pharmacoepidemiology strategies for products in early and late development as well as post-marketing phases.• Built collaborative and mutually beneficial relationships with external partners, including academic centers.• Contributed towards real-world evidence infrastructure by leading assessments of databases and platforms.• Established epidemiology team functions in alignment with strategic organization vision and mission.• Monitored and assessed progress status of real-world observational research projects.• Served as a primary oversight and point of escalation of research protocols, analysis plans, and study reports.• Assisted in the development of new research processes, tools, and protocols.• Drove process improvement initiatives and enhanced technical capabilities of the department. -
Director, PharmacoepidemiologyBristol Myers Squibb 2018 - 2021Lawrence Township, Nj, UsTEAM MANAGEMENT | PROJECT LIAISON | INNOVATION INITIATIVESMACHINE LEARNING | INSIGHTS GENERATION | EARLY CLINICAL DEVELOPMENT| LIFECYCLE MANAGEMENT• Managed professional and technical staff as a Pharmacoepidemiology Therapeutic Area Lead for Cardiovascular and Fibrosis, while supervising multiple activities across various projects and initiatives from concept to completion and in alignment with regulatory requirements.• Operated as a main contributor, cultivating strategic and holistic plans with colleagues, stakeholders, and external partners, including academic centers and research organizations.• Applied machine learning approaches to generate insights supporting clinical trial study design and indication finding.• Directed development of pharmacoepidemiological studies from inception to execution.• Led innovation initiatives, including developing and executing novel signal detection and evaluation methods while exploring analytical approaches, including Bayesian methods and machine learning tools.• Supervised early-/late-stage lifecycle management data generation for marketed drugs. -
Director, EpidemiologyBristol Myers Squibb 2017 - 2018Lawrence Township, Nj, UsREAL-WORLD DATA INSIGHTS GENERATION | DRUG SAFETY RESEARCHCLINICAL DEVELOPMENT/LIFECYCLE MANAGEMENT • Crafted best-in-class real-world data generation strategies to promote disease awareness and safety assessment during clinical development and lifecycle management.• Chaired Observational Protocol Review Committee to facilitate scientific review of observational study protocols.• Acted as an internal disease epidemiology expert for high-performing matrix development teams.• Oversaw planning and execution of studies on disease epidemiology and observational methods.• Identified evidence gaps and developed product-specific evidence plans with precision.• Worked in the design, execution, analysis, and interpretation of epidemiological and real-world studies.• Led clinical development and commercialization insights generation using real-world data and disease epidemiology knowledge.
-
Associate Director, EpidemiologyBristol Myers Squibb 2014 - 2017Lawrence Township, Nj, UsOBSERVATIONAL MANAGEMENT | ABSTRACT & MANUSCRIPT | PHARMACOEPIDEMIOLOGY• Led all phases of observational studies while representing pharmacoepidemiology on matrix teams across R&D.• Administered and directed interpretation of results, including abstract and manuscript preparation.• Coordinated development, implementation, monitoring, and evaluation of observational studies.
-
Senior Manager, EpidemiologyBristol Myers Squibb 2012 - 2014Lawrence Township, Nj, UsSAFETY ASSESSMENT & MANAGEMENT | CLINICAL DEVELOPMENTPOST-MARKETING PRODUCT CYCLE | RISK MANAGEMENT• Supported disease understanding and safety assessment during clinical development and post-marketing product cycle, including pre-approval risk management and REMS strategy.• Served as a subject matter expert for matrix teams, including safety management/development personnel.• Led efforts of professional staff engaged in the collection, monitoring, and analysis of epidemiological data.• Strategically coordinated, planned, and designed epidemiological research studies.
-
Senior Research AnalystHealthcore, Inc. 2011 - 2012Indianapolis, Indiana, UsPROJECT LIFECYCLE MANAGEMENT | RESEARCH DESIGNPHARMACEUTICAL CLIENT ENGAGEMENT | RESEARCH & DEVELOPMENT• Oversaw and supported multiple project phases, including research study design, methodologies, analytical tools, and reporting in alignment with pharmaceutical client requirements.• Analyzed prospective and retrospective data for pharmacoepidemiology research and analysis. -
Consultant Epidemiologist/Graduate Research AssistantGlaxosmithkline 2005 - 2011Brentford, Middlesex, GbRESEARCH MANAGEMENT | DRUG DEVELOPMENTINFECTIOUS DISEASE EPIDEMIOLOGY | GLOBAL RESEARCH & DEVELOPMENT• Provided scientific input to facilitate drug development teams regarding infectious disease epidemiology.• Contributed towards writing peer-reviewed journal articles/abstracts for conferences and meetings.• Reviewed proposals for global research teams and the HIV clinical investigator research award program.• Developed and implemented methods for acquiring, compiling, synthesizing, and extracting information.• Delivered comprehensive analysis and recommendations on issues based on detailed scientific understanding of infectious and emerging diseases.
Ella Nkhoma, Ph.D., M.B.A. Education Details
-
University Of North Carolina At Chapel HillBiostatistics -
Nyu Stern School Of BusinessAnd Entrepreneurship
-
Unt Health Science CenterEpidemiology
-
Austin CollegeBiology
Frequently Asked Questions about Ella Nkhoma, Ph.D., M.B.A.
What company does Ella Nkhoma, Ph.D., M.B.A. work for?
Ella Nkhoma, Ph.D., M.B.A. works for Regeneron
What is Ella Nkhoma, Ph.D., M.B.A.'s role at the current company?
Ella Nkhoma, Ph.D., M.B.A.'s current role is Data Science | Real-World Data | Quantitative Methods | Epidemiology/Biostatistics | Drug Discovery/Development | Lifecycle Management | Evidence Generation.
What schools did Ella Nkhoma, Ph.D., M.B.A. attend?
Ella Nkhoma, Ph.D., M.B.A. attended University Of North Carolina At Chapel Hill, Nyu Stern School Of Business, Unt Health Science Center, Austin College.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial